Mandara Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mandara Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mandara Trial Today - Breaking & Trending Today

MANDARA: Benralizumab Proves Noninferiority to Mepolizumab for EGPA

Published: February 23, 2024

The MANDARA trial results, published in NEJM, show benralizumab's noninferiority to mepolizumab in eosinophilic granulomatosis with polyangiitis, with potential for oral glucocorticoid discontinuation.

Source: hcplive.com

Related Topics:

Michael WechslerAstrazeneca Media CentreDrug AdministrationAmerican College Of RheumatologyOffice Of The CommissionerNational Jewish Health Michael WechslerNational Jewish HealthAmerican CollegeNew England JournalOrgan Drug DesignationBirmingham Vasculitis ActivityStandard DeviationCohen Family Asthma InstituteJewish National HealthEosinophilic GranulomatosisFasenra Orphan Drug DesignationAstrazeneca MediaBenralizumab FasenraMandara TrialBenralizumab In EgpaFasenra In Egpa